Goldman Sachs’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-68,301
| Closed | -$24K | – | 6027 |
|
|
2018
Q2 | $24K | Sell |
68,301
-3,261
| -5% | -$2.67K | ﹤0.01% | 5479 |
|
|
2018
Q1 | $107K | Sell |
71,562
-190,044
| -73% | -$332K | ﹤0.01% | 5263 |
|
|
2017
Q4 | $371K | Buy |
261,606
+160,621
| +159% | +$264K | ﹤0.01% | 5042 |
|
|
2017
Q3 | $231K | Buy |
100,985
+3,805
| +4% | +$5.09K | ﹤0.01% | 5668 |
|
|
2017
Q2 | $131K | Sell |
97,180
-24,314
| -20% | -$35.1K | ﹤0.01% | 6012 |
|
|
2017
Q1 | $260K | Buy |
121,494
+354
| +0.3% | +$1.33K | ﹤0.01% | 5553 |
|
|
2016
Q4 | $534K | Sell |
121,140
-92,643
| -43% | -$440K | ﹤0.01% | 5005 |
|
|
2016
Q3 | $1.04M | Buy |
213,783
+92,111
| +76% | +$420K | ﹤0.01% | 4367 |
|
|
2016
Q2 | $402K | Buy |
121,672
+90,831
| +295% | +$343K | ﹤0.01% | 5064 |
|
|
2016
Q1 | $109K | Buy |
+30,841
| New | +$159K | ﹤0.01% | 6039 |
|